Great visit at UT Austin for Edgar Achkar visiting professor with Deepak Agrawal and David Tang. and the entire GI Division Great program that continues to grow across all missions. You have much to be proud of!@DellMedIntMed @AmCollegeGastro

Congrats to @allisonkwong who won DOM award for best Mentor on resident research project at Stanford Research Symposium with Joshua Norman who also won for best research project . Recently published @ https://t.co/harSgBM8XM to improve priority for LT with HCC @Stanford_GI

🚨 BIG NEWS ALERT! 🚨 Ever wonder how to turn complicated research into clinical magic? ✨ Join us for Research to Reality: Enriching Clinical Practice at the ACG Annual Postgraduate Course! 📍 Phoenix, AZ 📅 October 25-26, 2025 Get ready for 2 days of cutting-edge

We had a wonderful visit from Dr Aleksander Krag who shared his insights on alcohol associated liver disease and the intersection with metabolic liver disease for the Peter Gregory lecture ⁦@Stanford_GI⁩ ⁦@EASLnews⁩ ⁦@AleksanderKrag⁩

There are disparities that we must address in those being listed for LT for ALD. Important findings presented by ⁦@ashley_jowell⁩ and ⁦@allisonkwong⁩ congratulations to both ⁦@Stanford_GI⁩ ⁦@AASLDtweets⁩

Dr Aparna Goel is taking us through the cholestatic liver disease update at the liver meeting in San Diego ⁦@Stanford_GI⁩ ⁦@AASLDtweets⁩ ⁦@WRayKimMD⁩

What are the limitations of AI in endoscopy? There is promise but need to link to outcomes. Likely a useful tool but still early days @RCPEdin @AmCollegeGastro @shahidadin @rkhsusa @AasmaShaukatMD

Prof Ron Hsu takes us through current and future strategies to target the gut microbiome to optimize GI health at RCPE/ACG/SSG symposium. ⁦@RCPEdin⁩ ⁦@AmCollegeGastro⁩ ⁦@rkhsusa⁩ ⁦@AasmaShaukatMD⁩

@ashley_jowell

Liver transplant recipients with food insecurity have higher rates of post-LT diabetes. Congrats to Stanford graduate and current Duke Medicine Resident Ashley Jowell for presenting her novel findings at today's plenary session @AmCollegeGastro @Stanford_GI @AMuir_DukeGI

Please join @AmCollegeGastro @RCPEdin Inaugural Hybrid GI Symposium: A Global Perspective #Nov6 obesity @DrGregorSmith MSALD @PaulYKwo IBD SirStanleyDavisonLecture DavidRubin @IBDMD ArtificialIntelligence debate @AasmaShaukatMD microbiome @rkhsusa https://t.co/Mt1HFDhlUL

Turning out the lights at DDW at the last session on inpatient Liver Consults Great discussions on hepatic complications of BMT, surgery in patients with liver disease, hbv reactivation and post Whipple complications ⁦@AASLDtweets⁩ ⁦@AmerGastroAssn⁩ ⁦⁦

Can GLP-RAs be beneficial in MetALD? Dr Amir Gougol @Stanford_GI notes that those with MetALD with at least 3 months of GLP exposure have reduced rates of hepatic decompensation and reduced mortality. Congratulations Amir. @Stanford_GI @AASLDtweets

Congratulations to Hepatologist, scientist, and entrepreneur extraordinaire Renu Dhanasekaran who today won the AGA innovator Shark Tank with her proposal to use AI to improve documentation and reimbursement for GI clinicians. Well done! @Stanford_GI @AASLDtweets @WRayKimMD

Despite high efficacy rates of DAAs for HCV/cirrhosis patients, we need improved strategies to ensure screening for HCC post-SVR. We still fall short in early detection of HCC in this population.Congrats Richie !@Stanford_GI @AASLDtweets

Can we refine our liver allocations for those with T2 tumors who require LT? Joshua Norman and Allison Kwong propose a model that improves wait list outcomes using MELD 3.0, tumor burden, and AFP. Congrats! @Stanford_GI @DDWMeeting

Dr Mindie Nguyen discusses strategies to reduce HCC mortality at Stanford Medicine Grans Rounds.Earlier diagnosis and improved treatment options must be combined with prevention and treatment of primary liver diseases including ALD MASLD and viral hepatitis ⁦@Stanford_GI⁩

Not all high creatinine is HRS AKI! With AKI in cirrhosis volume expand and withdraw diuretics. Address shock and infection ⁦@JasmohanBajaj⁩ ⁦@AmCollegeGastro⁩ at ACG BOG course in Las Vegas

Dr Chalasani taking us through the evaluation to DILi DILI is a diagnosis of exclusion Need good history, exclusion of competing etiologies

Our Stanford GI/Hepatology Fellow Mai Sedaki reports that in the obeticholic acid era, survival in those with decompensated cirrhosis due to PBC remained stable as assessed by MELD 3.0 with no excess mortality.👋👋👋#TLM @Stanford_GI @StanfordMed @AASLDtweets